SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...

Strategies to Remove Pre-Existing AAV Antibodies: IgG Enzymatic Degradation vs FcRn Inhibition. Presented by Yash Shah, PhD, ...

The relative valuations conducted in this article suggest that Cytek presents an undervaluation in the range of 16.43% to 109 ...

Experts set to speak at the NetZero Milan Expo-Summit 2025 on May 15 have told pv magazine that tunnel oxide passivated ...

Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...

One in three Americans is likely to be affected by a brain disorder in their lifetime. Many of these conditions, such as ...

The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But ...

This study seeks to investigate the role of the transcription factor Bcl11b/Ctip2 in regulating subcerebral projection neuron (SCPN) axon development through both cell-autonomous and ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Some hormone treatments block the action of estrogen as a way of slowing or stopping cancer development. Hormonal therapy is not for everyone. A family history of breast cancer or thyroid issues ...